Westlake Chemical Corp. diskutieren
Westlake Chemical Corp.
WKN: A0B7ET / Symbol: WLK / Name: Westlake Chem / Aktie / Chemie / Mid Cap /
63,00 €
1,61 %
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Royal Bank of Canada from $170.00 to $167.00. They now have an "outperform" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Piper Sandler from $155.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $144.00 price target on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $168.00 price target on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Barclays PLC from $175.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Wells Fargo & Company from $160.00 to $130.00. They now have an "overweight" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Truist Financial Co. from $168.00 to $166.00. They now have a "buy" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Royal Bank of Canada from $147.00 to $133.00. They now have an "outperform" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Truist Financial Co. from $166.00 to $155.00. They now have a "buy" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Citigroup Inc. from $130.00 to $116.00. They now have a "buy" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at UBS Group AG from $144.00 to $127.00. They now have a "buy" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Wells Fargo & Company from $130.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Truist Financial Co. from $155.00 to $132.00. They now have a "buy" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $75.00 price target on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Truist Financial Co. from $132.00 to $117.00. They now have a "buy" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Barclays PLC from $135.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Wells Fargo & Company from $110.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Royal Bank of Canada from $122.00 to $96.00. They now have an "outperform" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at UBS Group AG from $118.00 to $101.00. They now have a "buy" rating on the stock.
Ratings data for WLK provided by MarketBeat
Westlake Co. (NYSE: WLK) had its price target lowered by analysts at Royal Bank of Canada from $96.00 to $88.00. They now have an "outperform" rating on the stock.
Ratings data for WLK provided by MarketBeat
Neueste Beiträge
SVB_Leerink_LLC in Ultragenyx Pharmaceutical Inc. diskutieren